Oral GLP-1 Analog for Type 2 Diabetes on the Horizon.
JAMA · 2018
Last updated 2026-05-28| Journal | JAMA, 2018 |
|---|---|
| Citations | 8 |
| Relative citation ratio | 0.32 |
| NIH percentile | 20 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes |
Full record and abstract on PubMed 30120456 ↗